Amphotericin B Lipid Complex (Ablc™): A Molecular Rationale for the Attenuation of Amphotericin B Related Toxicities

References

• Janoff A. Lipids, Liposomes, and Rational Drug Design. Lab. Invest. 1992; 66: 655
   PubMed Web of Science ®Google Scholar
• New R. P. C., Chance M. L., Heath J. Antileishmanial activity of amphotericin and other antifungal agents entrapped in liposomes. J. Antimicrob. Chemother. 1981; 8: 371
   PubMed Web of Science ®Google Scholar
• Taylor R. L., Williams D. M., Craven P. C., Graybill J. R., Drutz D. J., Magee W. E. Amphotericin B in liposomes: a novel therapy for histoplasmosis. Annual Reviews of Respiratory Diseases. 1982; 125: 610
   PubMedGoogle Scholar
• Graybill J. R., Craven P. C., Taylor R. L., Williams D. M., Magee W. E. Treatment of murine cryptococcosis with liposome-associated amphotericin B. J. of Infectious Dis. 1982; 145: 748
   PubMed Web of Science ®Google Scholar
• Lopez-Berestein G., Mehta R., Hopfer R., Mehta K., Hersh E. M., Juliano R. Effects of sterols on the therapeutic efficacy of liposomal amphotericins in murine candidiasis. Cancer Drug Delivery. 1983; 1: 37
   PubMedGoogle Scholar
• Lopez-Berestein G., Mehta R., Hopfer R. L., Mills K., Kasi L., Mehta K., Fainstein V., Luna W., Hersh E. M., Juliano R. L. Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome encapsulated amphotericin B. J. of Infectious Dis. 1983; 147: 939
   PubMed Web of Science ®Google Scholar
• Ahrens J., Graybill J. R., Craven P. C., Taylor R. L. Treatment of experimental murine candidiasis with liposome associated amphotericin B. Sabouraudia J. of Medical and Veterinary Mycology. 1984; 22: 163
   Google Scholar
• Lopez-Berestein G., Hopfer R. L., Mehta R., Mehta K., Hersh E., Juliano R. L. Prophylaxis of Candida albicans infection in neutropenic mice with liposome-encapsulated amphotericin B. Antimicrob. Agents and Chemother. 1984; 25: 366
   PubMed Web of Science ®Google Scholar
• Hopfer R. L., Mills K., Mehta R., Lopez-Berestein G., Fainstein V., Juliano R. L. In vitro antifungal activities of amphotericin B and liposome-encapsulated amphotericin B. Antimicrob. Agents and Chemother 1984; 25: 287
   Web of Science ®Google Scholar
• Tremblay C., Barza M., Fiore C., Szoka F. Efficacy of liposome intercalated amphotericin B in the treatment of systemic candidiasis in mice. Antimicrob. Agents and Chemother. 1984; 26: 170
   PubMed Web of Science ®Google Scholar
• Lopez-Berestein G., Fainstein V., Hopfer R., Mehta K., Sullivan M. P., Keating M., Rosenblum M. G., Mehta R., Luna M., Hersh E. M., Reuben J., Juliano R. L., Bodey G. P. Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. J. of Infectious Diseases. 1985; 151: 704
   PubMed Web of Science ®Google Scholar
• Lopez-Berestein G., Bodey G. P., Frankel L. S., Mehta K. Treatment of hepatosplenic candidiasis with liposomal amphotericin B. J. of Clinical Oncology. 1987; 5: 310
   PubMed Web of Science ®Google Scholar
• Weber R. S., Lopez-Berestein G. Treatment of invasive Aspergillus sinusitis with liposomal amphotericin B. Laryngoscope. 1987; 97: 937
   PubMed Web of Science ®Google Scholar
• Mehta R., Lopez-Berestein G., Hopfer R., Mills K., Juliano R. Liposomal amphotericin B is toxic to fungal cells but not to mammalian cells. Biochim. Biophys. Acta. 1984; 770: 220
   Google Scholar
• Mehta R., Hsu M. J., Juliano R. L., Kranse H. J., Regen S. L. Polymerized phospholipid vesicles containing amphotericin B: evaluation of toxic and antifungal activities in vitro. J. Pharm Sci. 1986; 75: 579
   PubMed Web of Science ®Google Scholar
• Janoff A. S., Boni L. T., Popescu M. C., Minchey S. R., Cullis P. R., Madden T. D., Taraschi T., Gruner S. M., Shyamsunder E., Tate M. W., Mendelsohn R., Bonner D. Unusual lipid structures selectively reduce the toxicity of amphotericin B. Proc. Natl. Acad. Sci. USA. 1988; 85: 6122
   PubMed Web of Science ®Google Scholar
• Perkins W. R., Minchey S. R., Boni L. T., Swenson C. E., Popescu M. C., Pasternack R. F., Janoff A. S. Amphotericin B-phospholipid interactions responsible for reduced mammalian cell toxicity. Biochim. et Biophy. Acta. 1992; 1107: 271
   PubMed Web of Science ®Google Scholar
• Janoff A. S. Liposomes and Lipid Structures as Carriers of Amphotericin B. Eur. Clin. Micro. Infect. Dis. 1988; 146
   Google Scholar
• Dufourc E. J., Smith I. C. P., Jarrel H. C. Interaction of amphotericin B with membrane lipids as viewed by 2H-NMR. Biochim. Biophys. Acta. 1984; 778: 435
   PubMedGoogle Scholar
• Laggner P., Lohner K., Degovics G., Muller K., Schuster A. Structure and thermodynamics of the dihexadecylphosphatidylcholine-water system. Chem. Phys. Lipids. 1987; 44: 31
   PubMed Web of Science ®Google Scholar
• Lohner K., Schuster A., Degovics G., Muller L., Laggner P. Thermal phase behavior and structure of hydrated mixtures between dipalmitoyldihexadecylphosphatidylcholine. Chem. Phys. Lipids. 1987; 44: 61
   PubMed Web of Science ®Google Scholar
• Boni L. T., Minchey S. R., Perkins W. R., Ahl P. L., Slater J. L., Tate M. W., Gruner S. M., Janoff A. S. Curvature dependent induction of the interdigitated gel phase in DPPC vesicles. Biochim. Biophys. Acta. 1993; 1146: 247
   PubMed Web of Science ®Google Scholar
• Levin I. W., Lewis E. M. Fourier transform raman spectroscopy of biological materials. Anal. Chem. 1990; 62: 1101A
   PubMed Web of Science ®Google Scholar
• De Kruijff B., Demel R. A. Polyene antibiotic-sterol interactions in membranes of Acholeplasma laidlawii cells and lecithin liposomes III. Molecular structure of the polyene antibiotic-cholesterol complexes. Biochim. Biophys. Acta 1974; 339: 57
   PubMed Web of Science ®Google Scholar
• Minassian B., Flamm R. K., Whitney R. R., Kunselman L., Bender L., Summerill R., Bonner D. P. In Programs and Abstracts of the 30th Interscience Conference on Antimicrob. Agents Chemother. 1990, Abstract No. 847
   Google Scholar
• Barwicz J., Gareau R., Audet A., Morisset A., Villiard J., Gruda I. Inhibition of the interaction between lipoproteins and amphotericin B by some delivery systems. Biochem. Biophys. Res. Communications. 1991; 181: 722
   PubMed Web of Science ®Google Scholar
• Barwicz J., Christian S., Gruda I. Effects of the aggregation state of amphotericin B on its toxicity to mice. Antimicrob. Agents Chemother. 1992; 36: 2310
   PubMed Web of Science ®Google Scholar
• Wasan K. M., Brazeau G. A., Keyhani A., Hayman A., Lopez-Berestein G. Roles of liposome composition and temperature in distribution of amphotericin B in serum lipoproteins. Antimicrob. Agents Chemother. 1993; 37: 246
   PubMed Web of Science ®Google Scholar
• Clark J. M., Whitney R. R., Olsen S. J., George R. J., Swerdel M. R., Kunselman L., Bonner D. P. Amphotericin B lipid complex therapy of experimental fungal infections in mice. Antimicrob. Agents Chemother. 1991; 35: 615
   PubMed Web of Science ®Google Scholar
• Olsen S. J., Swerdel M. R., Blue B., Clark J. M., Bonner D. P. Tissue distribution of amphotericin B lipid complex in laboratory animals. J. Pharm. Pharmacol. 1991; 43: 831
   PubMed Web of Science ®Google Scholar
• Data on file. The Liposome Company, Inc
   Google Scholar
• Clemons K. V., Stevens D. A. Comparative efficacies of amphotericin B lipid complex and amphotericin B deoxycholate suspension against murine blastomycosis. Antimicrob. Agents Chemother. 1991; 35: 2144
   PubMed Web of Science ®Google Scholar
• Lee J., Allende M., Amantea M., Francis P., Peter J., Thomas V., Francesconi A., Lyman C., Schaufele R., Bacher J., Pizzo P., Walsh T. Pharmacokinetics and efficacy of amphotericin B lipid complex (ABLC) against chronic disseminated candidiasis in rabbits. Interscience Conference on Antimicrob. Agents and Chemother 1991, Abstract No. 579
   Google Scholar
• Lee J., Allende M., Dollenberg H., Garret K., Berenguer J., Francesconi A., Sein T., Lyman C., Francis P., Pizzo P., Walsh T. Reticuloendothelial loading with amphotericin B lipid complex (ABLC)-A novel pharmacodynamic approach to treatment of experimental hepatosplenic candidiasis. Interscience Conference on Antimicrob. Agents and Chemother 1992, Abstract No. 172
   Google Scholar
• Whitney R. R., Kunselman L., Clark J. M., Bonner D. P. Efficacy of amphotericin B lipid complex (ABLC) in cryptococcal meningitis in normal or immunocompromised mice. Interscience Conference on Antimicrob. Agents and Chemother 1989, Abstract No. 166
   Google Scholar
• Kan V. L., Bennett J. E., Amantea M. A., Smolskis M. C., McManus E., Grasela D. M., Sherman J. W. Comparative safety, tolerance, and pharmacokinetics of amphotericin B lipid complex and amphotericin B desoxycholate in healthy male volunteers. J. Infect. Dis. 1991; 164: 418
   PubMed Web of Science ®Google Scholar
• DeWitt S., Rossi C., Duchateau J., Braitman A., Gupta R., Clumeck N. Safety, tolerance and immunomodulatory effect of amphotericin B lipid complex (ABLC) in HIV infected subjects (S). Phase I/II Study. Interscience Conference on Antimicrob. Agents and Chemother 1991, Abstract No. 288
   Google Scholar
• Data on file. The Liposome Company, Inc
   Google Scholar
• Llanos-Cuentas A., Cieza J., Echevarria J., Chang J., Campos P., Bernardo J., Gonzalez D., Robbins M., Williams R. The safety and tolerance of amphotericin B lipid complex (ABLC) vs. amphotericin B desoxycholate (Fungizone) in patients with mucocutaneous leishmaniasis (MCL). Interscience Conference on Antimicrob. Agents and Chemother 1992, Abstract No. 234
   Google Scholar
• Sharkey P. K., Lipke R., Renteria A., Galgiani J., Catanzaro A., Diaz M., Kramer M., Whitney R., Gupta R. Amphotericin B lipid complex (ABLC) in treatment (Rx) of coccidioidomycosis (C). Interscience Conference on Antimicrob. Agents and Chemother 1991, Abstract No. 742
   PubMedGoogle Scholar
• Graybill J. R., Sharkey P. K., Vincent D., Johnson E., Fan Harvard P., Eng R., Kolokathis A., Mildvan D., Pollard R., Kerr L., Zalewska B., Gupta R. Amphotericin B lipid complex (ABLC) in treatment (Rx) of cryptococcal meningitis (CM) in patients with AIDS. Interscience Conference on Antimicrob. Agents and Chemother 1991, Abstract No. 289
   Google Scholar
• Data on file. The Liposome Company, Inc
   Google Scholar
• Bolard J., Seigneret M., Boudet G. Interaction between phospholipid bilayer membranes and the polyene antibiotic amphotericin B: lipid state and cholesterol content dependence. Biochim. Biophys. Acta. 1980; 599: 280
   PubMed Web of Science ®Google Scholar